Financial statements Arion Pharma

Balance sheet of Arion Pharma

Company age:
Age:
14 y. 1 m. 10 d.
Share capital:
Share capital:
5 000 PLN

Balance sheet data of ARION PHARMA

Year
2018
2019
2020
2021
2022
2023
Total assets 202 897,59 194 937,95 196 414,03 194 256,18 115 518,38 115 374,83
A. Fixed assets 7 930,29 5 744,37 3 388,35 0,00 - 0,00
B. Current assets 194 967,30 189 193,58 193 025,68 194 256,18 115 518,38 115 374,83
C. Share capital contributions (basic funds) - - - - - -
D. Own shares (stocks) - - - - - -
Total liabilities 202 897,59 194 937,95 196 414,03 194 256,18 115 518,38 115 374,83
A. Equity -771 903,71 -777 911,13 -791 443,53 -789 002,88 -863 789,10 -864 736,99
B. Liabilities and provisions for liabilities 974 801,30 972 849,08 987 857,56 983 259,06 979 307,48 980 111,82
I. Long-term liabilities 400 000,00 400 000,00 400 000,00 952 650,00 952 350,00 -
II. Short-term liabilities 574 801,30 572 849,08 587 857,56 30 609,06 26 957,48 -
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.